NASDAQ:DRTS
Alpha Tau Medical Ltd.
- Stock
Last Close
2.13
26/07 20:00
Market Cap
152.16M
Beta: 1.03
Volume Today
5.60K
Avg: 36.38K
PE Ratio
−8.90
PFCF: −36.22
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|
average inventory | -532.50K - | -532.50K 0% | ||||
average payables | 952.50K - | 1.11M 16.27% | 1.31M 18.56% | 1.99M 51.90% | ||
average receivables | 284.50K - | 356K 25.13% | 902K 153.37% | 558K 38.14% | ||
book value per share | -0.00 - | -0.12 4,267.36% | -0.51 312.59% | 1.66 423.35% | 1.22 26.78% | |
capex per share | -0.02 - | -0.06 191.34% | -0.04 22.30% | -0.01 67.13% | -0.09 548.44% | |
capex to depreciation | -19.59 - | -43.80 123.58% | -3.77 91.39% | -0.92 75.52% | -5.96 545.44% | |
capex to operating cash flow | 0.19 - | 0.52 177.64% | 0.25 52.30% | 0.04 84.72% | 0.36 841.54% | |
capex to revenue | ||||||
cash per share | 0.42 - | 0.68 63.59% | 0.46 31.94% | 1.65 255.26% | 1.22 25.58% | |
days of inventory on hand | ||||||
days payables outstanding | 872.06 - | |||||
days sales outstanding | ||||||
debt to assets | 0.04 - | 0.06 43.75% | ||||
debt to equity | 0.05 - | 0.08 60.70% | ||||
dividend yield | ||||||
earnings yield | -0.01 - | -0.01 4.94% | -0.04 215.79% | -0.17 306.90% | -0.14 16.17% | |
enterprise value | 681.15M - | 667.38M 2.02% | 640.81M 3.98% | 201.40M 68.57% | 205.60M 2.09% | |
enterprise value over ebitda | -99.13 - | -73.69 25.66% | -46.47 36.94% | -6.27 86.51% | -5.94 5.20% | |
ev to operating cash flow | -98.57 - | -92.04 6.63% | -54.25 41.06% | -8.43 84.45% | -11.45 35.75% | |
ev to sales | ||||||
free cash flow per share | -0.12 - | -0.16 34.32% | -0.22 33.77% | -0.39 78.96% | -0.35 9.99% | |
free cash flow yield | -0.01 - | -0.02 34.32% | -0.02 37.59% | -0.12 452.64% | -0.12 4.59% | |
graham net net | -0.05 - | -0.23 381.53% | -0.67 193.17% | 1.42 312.95% | 0.89 37.10% | |
graham number | 0.09 - | 0.61 576.98% | 2.16 255.92% | 4.46 106.41% | 3.39 23.90% | |
income quality | 0.82 - | 0.82 0.00% | 0.43 46.94% | 0.71 63.29% | 0.62 12.92% | |
intangibles to total assets | 0 - | 0 | 0 | 0 | 0 | |
interest coverage | -18.17 - | -914.87 4,936.12% | ||||
interest debt per share | 0.11 - | 0.10 11.72% | ||||
inventory turnover | ||||||
invested capital | 0.05 - | 0.08 60.70% | ||||
market cap | 682.98M - | 682.98M 0% | 664.04M 2.77% | 202.04M 69.57% | 208.13M 3.02% | |
net current asset value | -1.92M - | -13.96M 626.11% | -44.35M 217.63% | 91.98M 307.40% | 62.84M 31.68% | |
net debt to ebitda | 0.27 - | 1.72 546.34% | 1.68 2.17% | 0.02 98.81% | 0.07 265.82% | |
net income per share | -0.13 - | -0.13 4.94% | -0.40 207.04% | -0.53 31.76% | -0.42 20.91% | |
operating cash flow per share | -0.10 - | -0.11 4.93% | -0.17 62.90% | -0.38 115.16% | -0.26 31.13% | |
payables turnover | 0.42 - | |||||
receivables turnover | ||||||
research and ddevelopement to revenue | ||||||
return on tangible assets | -0.27 - | -0.17 37.51% | -0.65 285.40% | -0.28 56.50% | -0.27 3.38% | |
revenue per share | ||||||
roe | 43.85 - | 1.05 97.60% | 0.78 25.58% | -0.32 140.75% | -0.35 8.02% | |
roic | 42.23 - | 1.12 97.36% | 0.40 64.48% | -0.28 169.86% | -0.37 31.80% | |
sales general and administrative to revenue | ||||||
shareholders equity per share | -0.00 - | -0.12 4,267.36% | -0.51 312.59% | 1.66 423.35% | 1.22 26.78% | |
stock based compensation to revenue | ||||||
tangible asset value | -193K - | -8.43M 4,267.36% | -34.78M 312.59% | 105.66M 403.81% | 84.47M 20.05% | |
tangible book value per share | -0.00 - | -0.12 4,267.36% | -0.51 312.59% | 1.66 423.35% | 1.22 26.78% | |
working capital | 28.48M - | 45.37M 59.31% | 28.24M 37.76% | 102.14M 261.73% | 78.65M 22.99% |
All numbers in USD (except ratios and percentages)